Canadian IPOs All But Vanished in 2022: Here’s How 3 New Listings Did

A $9.2 billion Canadian IPO market in 2021 slumped to record lows in 2022. Two IPOs produced market-beating returns. Here how Bausch + Lomb Corp stock and others performed.

| More on:

Initial public offerings (IPOs) are spectacular events in the Canadian stock market. They present investors with more opportunities to choose from, provide more chances of hitting jackpot-type returns, and offer more options to improve portfolio diversification. However, following the record-breaking year 2021, when Canadian IPOs raised $10.2 billion from the public market, the IPO market abruptly cooled off to record lows in 2022.

About 77 new companies graced Canadian exchanges in 2021. They raised a record $9.2 billion. The number excludes Special Purpose Acquisition Companies (SPACs) and capital pool funds. The market turned south in 2022. The number of new Canadian IPOs declined to 42 companies in 2022, raising a paltry $1.3 billion.

Why Canadian IPOs vanished in 2022

The Canadian and global investment market environment abruptly changed between 2021 and 2022.

Investor spirits were high and optimism reigned in the markets in 2021. Easy money flooded the capital markets, as interest rates touched record lows. The TSX soared by 21% for the year. It was a great time for companies to raise new capital in the market by going public. It was the best time for early investors to sell stocks and exit long-held private investments to new shareholders through IPOs.

Moods changed in 2022. Investors freaked out, as “transitory” inflation threatened to stay. Interest rates rose at a record pace, and markets tumbled. Growth stocks with frothy valuations and weak fundamentals got clobbered.

Very few investors, IPO sponsors, founders, and company executives were willing to bring new companies onto exchanges when stock prices were coming down. Not only would their compensation be too low, but the risk of losing money was also just too high.

However, not all 2022 IPOs lost investors’ money. Here’s how the three largest Canadian news listings performed during their first calendar year trading on the public stock market.

Kiwetinohk Energy

Natural gas producer and fast-growing renewable energy company Kiwetinohk Energy (TSX:KEC) was listed on the TSX and started trading on January 14, 2022. The company chose a brilliant time to go public. Rapid production growth and soaring oil and natural gas prices gave new IPO investors great reasons to invest in the ambitious natural gas and green energy firm.

At the time of going public, management guided for 2022 production of 13,000-15,000 barrels of oil equivalent per day (boe/d). Full-year 2022 production averaged 17,900 boe/d. The company overdelivered on its production promises, and surging oil and natural gas prices amplified the financial impact.

Revenue and funds flow exceeded prior market estimates. KEC stock price closed 16.6% higher for 2022.

Ivanhoe Electric

Technology and mineral exploration company Ivanhoe Electric (TSX:IE) went public in a private equity-backed, dual-listed IPO in June 2022 that raised US$169 million. Shares also trade on the NYSE.

Ivanhoe Electric’s most attractive asset is its disruptive Typhoon, a geophysical survey technology obtained from its parent company I-Pulse. The Typhoon technology can cost effectively detect copper, gold, silver, and nickel, water, and oil at depths deeper than other conventional technologies’ given ranges, or where a cover hides deposits, and across vast tracts of land.

The company uses its survey technology exclusively, however, a recent US$126.4 million investment deal with Saudi Arabia’s mining giant Ma’aden will extend Typhoon access to a third party for the first time.

Ivanhoe Electric stock rose 16.9% during 2022. IE stock is up 26.1% since its IPO and trades 8.4% higher so far this year.

Bausch + Lomb

Bausch + Lomb (TSX:BLCO) is an $8.1 billion company that spun off from parent company Bausch Health in a dual-listed IPO on the TSX and the New York Stock Exchange in May 2022. The company is a global eye healthcare giant, with significant clout in the populous markets of India and China.

The parent company Bausch Health retains a controlling stake in the spin-off and donated its Chief Executive Officer Joseph C. Papa to the newly listed company. Papa is set to leave Bausch + Lomb in March this year.

Reported net earnings significantly declined in 2022, even as revenue remained stable. Operating costs and interest costs have increased as the company became a standalone business weaned from its parent.

BLCO stock lost 17.9% of its value post-IPO in 2022. That said, shares are up 7.5% year to date.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

bulb idea thinking
Stocks for Beginners

2 No-Brainer Stocks to Buy With Less Than $1,000

There are some stocks that are risky to even consider, but not these two! Consider these stocks if you want…

Read more »

space ship model takes off
Investing

These 2 Small-cap Stocks Offer Massive Return Potential

If you invest exclusively in blue chips and large caps, you may miss out on some fantastic growth opportunities that…

Read more »

coins jump into piggy bank
Investing

Could This Undervalued Canadian Stock Be Your Ticket to Millionaire Status?

Here's why Manulife Financial (TSX:MFC) certainly looks like an undervalued Canadian stock worth buying right now for long-term investors.

Read more »

ways to boost income
Dividend Stocks

TFSA Investors: 3 Dividend Stocks to Buy and Hold Forever

These dividend stocks are likely to consistently increase their dividends, making them attractive investment for your TFSA portfolio.

Read more »

open vault at bank
Investing

2 Defence Stocks That Canadian Investors Should Keep an Eye on in November

Canadians should keep an eye on two TSX stocks that could rise higher as global defence demand rises.

Read more »

how to save money
Dividend Stocks

Passive-Income Seekers: Invest $10,000 for $59.75 Monthly Income

Passive-income seekers can transform their money into monthly cash flow streams through dividend investing.

Read more »

happy woman throws cash
Dividend Stocks

2 Canadian Dividend Stars Set for Strong Returns

You can add these two fundamentally strong Canadian dividend stocks to your portfolio now and expect steady income and strong…

Read more »

Man in fedora smiles into camera
Dividend Stocks

Is it Better to Collect the CPP at 60, 65, or 70?

Canadian retirees can consider supporting their CPP benefit by investing in blue-chip dividend stocks with high yields.

Read more »